))
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Manage episode 513630725 series 3648058
Content provided by Dr. Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Dr Laura Huppert from the University of California, San Francisco, discusses approved and investigational antibody-drug conjugates in the current and future management of HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
78 episodes
Share
